Viroclinics Biosciences
Rotterdam, Zuid-Holland, The Netherlands
About Viroclinics Biosciences
Viroclinics Biosciences is a leading contract research and clinical laboratory service company providing diagnostic and preclinical studies along with drug development for prevention and treatment of virus infections. With our extensive experience in respiratory viruses, in particular influenza, our mission is to improve human and animal health by serving the biopharmaceutical community with state-of-the-art diagnostics, custom-made models in (pre)clinical drug testing, and expert advice on development of antivirals and vaccines. We offer a full range of virology services for new drug development programs and post-marketing surveillance of existing drugs and vaccines, ranging from traditional virology assays to the latest deep sequencing protocols for a very broad range of viruses. Our BSL2 and BSL3 labs enable us to perform analysis according to international ISO 15189 accreditation. Close cooperation with the Erasmus MC Viroscience lab brings the combined benefits of a broad range of knowledge, experience and skills to our work
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Website: viroclinics.com
- Phone: 31 10 704 4062
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/viroclinics-biosciences-2588594 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.